Clinical Trials
4 trialsNCT02184416 2026-02-27
ADONIS
Pfizer
Completed
NCT01210482 2024-09-25
Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Pfizer
Completed
NCT01367457 2016-04-27
INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus
Pfizer
Completed
NCT01781442 2013-05-01
A Post Marketing Surveillance As Required By Philippine Food And Drug Administration
Pfizer
Withdrawn